Table 2.

Frequency of ICOS+ CD4 T cells from normal healthy donors and baseline blood samples from cancer patients

All samplesHealthy donorsPatients with cancer (localized bladder cancer, will receive ipilimumab therapy)Patients with cancer (metastatic melanoma, will receive ipilimumab therapy)Patients with cancer (metastatic melanoma, will receive gp100 vaccine therapy)
N5610122410
Median222.512
Mean2.221.902.362.082.7
SD1.390.991.181.671.25
Preference0.3230.7370.128